1. Jiang, Zhongxing, Sun, Hao, Yu, Jifeng, Tian, Wenzhi, Song, Yongping. 2021. Targeting CD47 for cancer immunotherapy. In Journal of hematology & oncology, 14, 180. doi:10.1186/s13045-021-01197-w. https://pubmed.ncbi.nlm.nih.gov/34717705/
2. Hayat, Seyed Mohammad Gheibi, Bianconi, Vanessa, Pirro, Matteo, Hatamipour, Mahdi, Sahebkar, Amirhossein. 2019. CD47: role in the immune system and application to cancer therapy. In Cellular oncology (Dordrecht, Netherlands), 43, 19-30. doi:10.1007/s13402-019-00469-5. https://pubmed.ncbi.nlm.nih.gov/31485984/
3. Hu, Li-Yang, Zhuang, Wei-Tao, Chen, Mao-Jian, Zhang, Li, Fang, Wen-Feng. 2024. EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47. In Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 19, 1186-1200. doi:10.1016/j.jtho.2024.03.019. https://pubmed.ncbi.nlm.nih.gov/38553005/
4. Yu, Lan, Ding, Yi, Wan, Ting, Huang, He, Liu, Jihong. 2021. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer. In Frontiers in immunology, 12, 768115. doi:10.3389/fimmu.2021.768115. https://pubmed.ncbi.nlm.nih.gov/34966389/
5. Hu, Tuo, Liu, Huashan, Liang, Zhenxing, Wu, Xianrui, Lan, Ping. 2020. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis. In Theranostics, 10, 4056-4072. doi:10.7150/thno.40860. https://pubmed.ncbi.nlm.nih.gov/32226539/
6. Shi, Yaoyao, Zheng, Wenxin, Yang, Kaiting, Weichselbaum, Ralph R, Fu, Yang-Xin. . Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. In The Journal of experimental medicine, 217, . doi:10.1084/jem.20192282. https://pubmed.ncbi.nlm.nih.gov/32142585/